SCHEMBL7705247

SCHEMBL7705247

Cc1cccc(C)c1N1[CH]CN(CC(O)CCc2ccccc2Cl)CC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.39
KMT2A Q03164 4/20 0.39
LMNA P02545 2/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
KCNH2 Q12809 1/20 0.39
MAPT P10636 2/20 0.37
HTT P42858 2/20 0.37
USP2 O75604 1/20 0.37
DRD2 P14416 3/20 0.37
DRD3 P35462 3/20 0.37
SLC6A2 P23975 1/20 0.36
SLC6A4 P31645 1/20 0.36
SLC6A3 Q01959 1/20 0.36
ALDH1A1 P00352 3/20 0.36
GAA P10253 2/20 0.36
KDM4E B2RXH2 1/20 0.36
NPSR1 Q6W5P4 1/20 0.35
P2RX7 Q99572 1/20 0.35
MAPK1 P28482 1/20 0.34
CXCR4 P61073 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7711760 0.87 MEN1 (0.39) MEN1KMT2ALMNASMN1; SMN2SLC6A2
SCHEMBL7705250 0.81 MEN1 (0.38) MEN1KMT2ALMNASMN1; SMN2SLC6A4
SCHEMBL7713731 0.80 ABCB1 (0.42) MEN1KMT2ALMNASMN1; SMN2MAPT
SCHEMBL7708649 0.77 SLC6A3 (0.45) MEN1KMT2ALMNASMN1; SMN2DRD2
SCHEMBL7711594 0.76 LMNA (0.47) MEN1KMT2ALMNASMN1; SMN2KCNH2
SCHEMBL7711567 0.76 CHRNA7 (0.44) MEN1KMT2ALMNASMN1; SMN2MAPT
SCHEMBL7711797 0.74 MEN1 (0.48) MEN1KMT2ALMNASMN1; SMN2KCNH2
SCHEMBL7708651 0.74 CACNA1G (0.43) MEN1KMT2ALMNASMN1; SMN2KCNH2
SCHEMBL6279868 0.74 CYP3A4 (0.58) MEN1KMT2ALMNAKCNH2MAPT
SCHEMBL7705235 0.70 CYP2D6 (0.54) MEN1KMT2ALMNASMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1259493-A2 SUBSTITUTED PIPERAZINE COMPOUNDS CV THERAPEUTICS, INC. (US) 2002-11-27 EP claimed
WO-2001062744-A2 SUBSTITUTED PIPERAZINE COMPOUNDS CV THERAPEUTICS, INC. (US) 2001-08-30 WO claimed
EP-1259493-A2 SUBSTITUTED PIPERAZINE COMPOUNDS CV THERAPEUTICS, INC. (US) 2002-11-27 EP disclosed
WO-2001062744-A2 SUBSTITUTED PIPERAZINE COMPOUNDS CV THERAPEUTICS, INC. (US) 2001-08-30 WO disclosed